Dr Lalchandani Labs Ltd - 541299 - Intimation Of 05Th Annual General Meeting
This is to inform you that the 05th Annual General Meeting of the Company is scheduled to be held on Friday, September 30, 2022, at 3.00 P.M. on the 1st Floor, 19C Club Road, Punjabi Bagh West, New Delhi-110024. Dr Lalchandani Labs Ltd - 541299 - Fixes Book Closure For AGM
Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer books will remain closed from Wednesday, September 21, 2022, to Friday, September 30, 2022 (both days inclusive) for the purpose of the forthcoming 05th Annual General Meeting. Dr Lalchandani Labs Ltd - 541299 - Board Meeting Outcome for Outcome Of Board Meeting Held On 06.09.2022
Outcome of Board Meeting held on 06th September 2022, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr Lalchandani Labs Ltd - 541299 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, it is hereby informed that CS Swati Poddar is being resigned from the post of Company Secretary and Compliance Officer as KMP of DR LALCHANDANI LABS LIMITED from the service from the Company with the effect from close of the business hours of August 06, 2022. Request you to please take the same on your records. Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SWATI PODDARDesignation :- Company Secretary and Compliance Officer Dr Lalchandani Labs Ltd - 541299 - Outcome Of Board Meeting Held On 30Th May, 2022, As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Approval of Standalone Audited Financial Results For The Half Yearly and Year Ended 31st March, 2022 Dr Lalchandani Labs Ltd - 541299 - Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May, 2022, As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at their meeting held on Monday, the 30th day of May 2022, has approved, inter-alia, the following Dr Lalchandani Labs Ltd - 541299 - Non-Applicability Certificate For Corporate Governance And Annual Secretarial Compliance Report
Dr Lalchandani Labs Limited would like to inform you that the Annual Secretarial Compliance Report under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirement) (Amendment) Regulations, 2018 read with SEBI Circular dated 08.02.2019 and BSE circular dated 09.05.2019 and 14.05.2019 is not applicable to the Company. Further, we would like to clarify that Dr Lalchandani Labs Limited (''Company'') is listed on the SME platform of BSE. In view of the above, the company is exempted under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, and consequently, the company is also exempted from submitting the Annual Secretarial Compliance Report for the year ended March 31, 2022, to the Stock Exchange. Dr Lalchandani Labs Ltd - 541299 - Board Meeting Intimation for The Board Meeting As Per Regulation 29 Of SEBI(Listing Obligations And Disclosure Requirement) Regulations, 2015.
Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors has been scheduled to be held on Monday, May 30, 2022, at 5.00 pm to, inter alia, consider and decide the following business matters: 1. To consider and approve Audited Financial Results of the Company for the year ended March 31, 2022. 2. Any other Business matter, with the permission of the Chair.